BSX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Boston Scientific Corp (BSX).


$131.64B Market Cap.

As of 02/18/2025 5:00 PM ET (MRY) • Disclaimer

BSX Market Cap. (MRY)


BSX Shares Outstanding (MRY)


BSX Assets (MRY)


Total Assets

$39.40B

Total Liabilities

$17.39B

Total Investments

$0

BSX Income (MRY)


Revenue

$16.75B

Net Income

$1.85B

Operating Expense

$8.88B

BSX Cash Flow (MRY)


CF Operations

$3.44B

CF Investing

-$5.69B

CF Financing

$1.81B

BSX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

BSX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$39,395,000,000 (12.12%)

$35,136,000,000 (8.21%)

$32,469,000,000 (0.74%)

$32,229,000,000 (4.72%)

Assets Current

$6,920,000,000 (6.23%)

$6,514,000,000 (13.09%)

$5,760,000,000 (-8.82%)

$6,317,000,000 (-5.63%)

Assets Non-Current

$32,475,000,000 (13.46%)

$28,622,000,000 (7.16%)

$26,709,000,000 (3.08%)

$25,912,000,000 (7.59%)

Goodwill & Intangible Assets

$23,773,000,000 (16.59%)

$20,390,000,000 (8.33%)

$18,822,000,000 (3.94%)

$18,109,000,000 (14.12%)

Shareholders Equity

$21,770,000,000 (12.90%)

$19,282,000,000 (9.73%)

$17,573,000,000 (5.72%)

$16,622,000,000 (8.46%)

Property Plant & Equipment Net

$3,294,000,000 (15.22%)

$2,859,000,000 (16.88%)

$2,446,000,000 (8.61%)

$2,252,000,000 (8.06%)

Cash & Equivalents

$414,000,000 (-52.14%)

$865,000,000 (-6.79%)

$928,000,000 (-51.79%)

$1,925,000,000 (11.01%)

Accumulated Other Comprehensive Income

$275,000,000 (461.22%)

$49,000,000 (-81.78%)

$269,000,000 (2.28%)

$263,000,000 (27.05%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$2,810,000,000 (13.12%)

$2,484,000,000 (33.05%)

$1,867,000,000 (15.96%)

$1,610,000,000 (19.17%)

Trade & Non-Trade Receivables

$2,558,000,000 (14.81%)

$2,228,000,000 (13.10%)

$1,970,000,000 (10.80%)

$1,778,000,000 (16.13%)

Trade & Non-Trade Payables

$960,000,000 (1.91%)

$942,000,000 (9.28%)

$862,000,000 (8.56%)

$794,000,000 (54.78%)

Accumulated Retained Earnings (Deficit)

$2,673,000,000 (226.37%)

$819,000,000 (209.20%)

-$750,000,000 (46.12%)

-$1,392,000,000 (41.46%)

Tax Assets

$3,962,000,000 (-4.67%)

$4,156,000,000 (-1.19%)

$4,206,000,000 (-3.24%)

$4,347,000,000 (-1.29%)

Tax Liabilities

$155,000,000 (15.67%)

$134,000,000 (-6.94%)

$144,000,000 (-53.55%)

$310,000,000 (-6.06%)

Total Debt

$10,746,000,000 (18.06%)

$9,102,000,000 (1.87%)

$8,935,000,000 (-1.43%)

$9,065,000,000 (-0.85%)

Debt Current

$1,778,000,000 (234.84%)

$531,000,000 (2555.00%)

$20,000,000 (-92.34%)

$261,000,000 (1907.69%)

Debt Non-Current

$8,968,000,000 (4.63%)

$8,571,000,000 (-3.86%)

$8,915,000,000 (1.26%)

$8,804,000,000 (-3.57%)

Total Liabilities

$17,392,000,000 (11.44%)

$15,606,000,000 (4.77%)

$14,896,000,000 (-4.56%)

$15,607,000,000 (1.01%)

Liabilities Current

$6,399,000,000 (29.72%)

$4,933,000,000 (29.71%)

$3,803,000,000 (-11.02%)

$4,274,000,000 (16.11%)

Liabilities Non-Current

$10,993,000,000 (3.00%)

$10,673,000,000 (-3.79%)

$11,093,000,000 (-2.12%)

$11,333,000,000 (-3.71%)

BSX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$16,747,000,000 (17.61%)

$14,240,000,000 (12.29%)

$12,682,000,000 (6.68%)

$11,888,000,000 (19.92%)

Cost of Revenue

$5,257,000,000 (20.99%)

$4,345,000,000 (9.83%)

$3,956,000,000 (6.60%)

$3,711,000,000 (7.10%)

Selling General & Administrative Expense

$5,984,000,000 (15.30%)

$5,190,000,000 (14.82%)

$4,520,000,000 (3.69%)

$4,359,000,000 (15.10%)

Research & Development Expense

$1,615,000,000 (14.21%)

$1,414,000,000 (6.88%)

$1,323,000,000 (9.88%)

$1,204,000,000 (5.34%)

Operating Expenses

$8,885,000,000 (17.65%)

$7,552,000,000 (6.68%)

$7,079,000,000 (1.43%)

$6,979,000,000 (6.93%)

Interest Expense

$305,000,000 (15.09%)

$265,000,000 (-43.62%)

$470,000,000 (37.83%)

$341,000,000 (-5.54%)

Income Tax Expense

$436,000,000 (10.94%)

$393,000,000 (-11.29%)

$443,000,000 (1130.56%)

$36,000,000 (1700.00%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$1,846,000,000 (15.95%)

$1,592,000,000 (128.08%)

$698,000,000 (-32.95%)

$1,041,000,000 (1369.51%)

Net Income to Non-Controlling Interests

-$8,000,000 (-700.00%)

-$1,000,000 (-200.00%)

$1,000,000 (0.00%)

$1,000,000 (0%)

Net Income

$1,854,000,000 (16.38%)

$1,593,000,000 (128.55%)

$697,000,000 (-32.98%)

$1,040,000,000 (1368.29%)

Preferred Dividends Income Statement Impact

$0 (0%)

$23,000,000 (-58.18%)

$55,000,000 (0.00%)

$55,000,000 (66.67%)

Net Income Common Stock

$1,853,000,000 (18.03%)

$1,570,000,000 (144.55%)

$642,000,000 (-34.82%)

$985,000,000 (956.52%)

Weighted Average Shares

$1,471,500,000 (1.27%)

$1,453,000,000 (1.57%)

$1,430,500,000 (0.58%)

$1,422,300,000 (0.40%)

Weighted Average Shares Diluted

$1,485,900,000 (1.53%)

$1,463,500,000 (1.65%)

$1,439,700,000 (0.41%)

$1,433,800,000 (1.21%)

Earning Before Interest & Taxes (EBIT)

$2,595,000,000 (15.28%)

$2,251,000,000 (39.81%)

$1,610,000,000 (13.62%)

$1,417,000,000 (404.27%)

Gross Profit

$11,490,000,000 (16.12%)

$9,895,000,000 (13.40%)

$8,726,000,000 (6.71%)

$8,177,000,000 (26.81%)

Operating Income

$2,605,000,000 (11.18%)

$2,343,000,000 (42.26%)

$1,647,000,000 (37.48%)

$1,198,000,000 (1616.46%)

BSX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$5,687,000,000 (-120.94%)

-$2,574,000,000 (-28.00%)

-$2,011,000,000 (-25.92%)

-$1,597,000,000 (-288.56%)

Net Cash Flow from Financing

$1,814,000,000 (36180.00%)

$5,000,000 (100.91%)

-$548,000,000 (-476.84%)

-$95,000,000 (-132.42%)

Net Cash Flow from Operations

$3,435,000,000 (37.24%)

$2,503,000,000 (64.02%)

$1,526,000,000 (-18.40%)

$1,870,000,000 (24.01%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$450,000,000 (-542.86%)

-$70,000,000 (93.28%)

-$1,042,000,000 (-702.31%)

$173,000,000 (-87.54%)

Net Cash Flow - Business Acquisitions and Disposals

-$4,640,000,000 (-144.21%)

-$1,900,000,000 (-21.72%)

-$1,561,000,000 (-35.39%)

-$1,153,000,000 (-760.45%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$2,000,000 (-96.43%)

$56,000,000 (273.33%)

$15,000,000 (0%)

Capital Expenditure

-$767,000,000 (-13.29%)

-$677,000,000 (-33.79%)

-$506,000,000 (-10.48%)

-$458,000,000 (-65.34%)

Issuance (Repayment) of Debt Securities

$1,827,000,000 (45775.00%)

-$4,000,000 (97.58%)

-$165,000,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$143,000,000 (13.49%)

$126,000,000 (51.81%)

$83,000,000 (38.33%)

$60,000,000 (-87.80%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$11,000,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$266,000,000 (14.16%)

$233,000,000 (5.91%)

$220,000,000 (13.40%)

$194,000,000 (14.12%)

Depreciation Amortization & Accretion

$1,269,000,000 (6.10%)

$1,196,000,000 (5.28%)

$1,136,000,000 (3.93%)

$1,093,000,000 (-2.67%)

BSX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

68.60% (-1.29%)

69.50% (1.02%)

68.80% (0.00%)

68.80% (5.85%)

Profit Margin

11.10% (0.91%)

11.00% (115.69%)

5.10% (-38.55%)

8.30% (791.67%)

EBITDA Margin

23.10% (-4.55%)

24.20% (11.52%)

21.70% (2.84%)

21.10% (48.59%)

Return on Average Equity (ROAE)

9.00% (5.88%)

8.50% (129.73%)

3.70% (-39.34%)

6.10% (862.50%)

Return on Average Assets (ROAA)

4.90% (6.52%)

4.60% (130.00%)

2.00% (-35.48%)

3.10% (875.00%)

Return on Sales (ROS)

15.50% (-1.90%)

15.80% (24.41%)

12.70% (6.72%)

11.90% (325.00%)

Return on Invested Capital (ROIC)

13.20% (5.60%)

12.50% (37.36%)

9.10% (9.64%)

8.30% (453.33%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

70.89 (32.43%)

53.53 (-47.94%)

102.82 (67.01%)

61.56 (113.70%)

Price to Sales Ratio (P/S)

7.85 (33.04%)

5.9 (13.03%)

5.22 (2.70%)

5.08 (-1.09%)

Price to Book Ratio (P/B)

6.05 (37.68%)

4.39 (16.47%)

3.77 (3.54%)

3.64 (8.43%)

Debt to Equity Ratio (D/E)

0.8 (-1.24%)

0.81 (-4.60%)

0.85 (-9.69%)

0.94 (-6.85%)

Earnings Per Share (EPS)

1.26 (16.67%)

1.08 (140.00%)

0.45 (-34.78%)

0.69 (962.50%)

Sales Per Share (SPS)

11.38 (16.13%)

9.8 (10.55%)

8.87 (6.07%)

8.36 (19.45%)

Free Cash Flow Per Share (FCFPS)

1.81 (44.23%)

1.26 (76.30%)

0.71 (-28.20%)

0.99 (14.27%)

Book Value Per Share (BVPS)

14.79 (11.48%)

13.27 (8.02%)

12.29 (5.12%)

11.69 (8.03%)

Tangible Assets Book Value Per Share (TABVPS)

10.62 (4.60%)

10.15 (6.38%)

9.54 (-3.91%)

9.93 (-5.66%)

Enterprise Value Over EBIT (EV/EBIT)

54 (31.71%)

41 (-10.87%)

46 (-4.17%)

48 (-77.03%)

Enterprise Value Over EBITDA (EV/EBITDA)

36.24 (34.84%)

26.88 (-0.97%)

27.14 (0.65%)

26.96 (-35.61%)

Asset Turnover

0.44 (5.48%)

0.42 (6.87%)

0.39 (4.24%)

0.38 (16.36%)

Current Ratio

1.08 (-18.11%)

1.32 (-12.87%)

1.51 (2.50%)

1.48 (-18.75%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$2,668,000,000 (46.11%)

$1,826,000,000 (79.02%)

$1,020,000,000 (-27.76%)

$1,412,000,000 (14.70%)

Enterprise Value (EV)

$140,025,270,960 (51.15%)

$92,637,654,338 (24.31%)

$74,519,043,018 (10.12%)

$67,671,680,423 (15.10%)

Earnings Before Tax (EBT)

$2,290,000,000 (15.31%)

$1,986,000,000 (74.21%)

$1,140,000,000 (5.95%)

$1,076,000,000 (1445.00%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$3,864,000,000 (12.10%)

$3,447,000,000 (25.53%)

$2,746,000,000 (9.40%)

$2,510,000,000 (78.77%)

Invested Capital

$19,555,000,000 (8.34%)

$18,050,000,000 (1.11%)

$17,851,000,000 (5.09%)

$16,986,000,000 (-8.86%)

Working Capital

$521,000,000 (-67.05%)

$1,581,000,000 (-19.21%)

$1,957,000,000 (-4.21%)

$2,043,000,000 (-32.19%)

Tangible Asset Value

$15,622,000,000 (5.94%)

$14,746,000,000 (8.05%)

$13,647,000,000 (-3.35%)

$14,120,000,000 (-5.29%)

Market Capitalization

$131,642,270,960 (55.44%)

$84,690,654,338 (27.79%)

$66,273,043,018 (9.48%)

$60,533,680,423 (17.59%)

Average Equity

$20,693,750,000 (11.49%)

$18,561,000,000 (7.29%)

$17,299,750,000 (6.88%)

$16,186,250,000 (7.35%)

Average Assets

$37,812,500,000 (11.48%)

$33,918,000,000 (5.22%)

$32,235,500,000 (2.19%)

$31,543,500,000 (2.95%)

Invested Capital Average

$19,634,500,000 (9.29%)

$17,965,750,000 (1.41%)

$17,716,750,000 (3.42%)

$17,131,500,000 (-6.68%)

Shares

1,473,827,485 (0.60%)

1,464,982,777 (2.28%)

1,432,311,282 (0.51%)

1,424,992,477 (-0.48%)